Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIHUAN PHARM

1.680
+0.0100.60%
Volume:18.39M
Turnover:30.60M
Market Cap:15.42B
PE:-65.72
High:1.680
Open:1.670
Low:1.640
Close:1.670
52wk High:1.710
52wk Low:0.491
Shares:9.18B
HK Float Shares:9.18B
Volume Ratio:0.40
T/O Rate:0.20%
Dividend:0.01
Dividend Rate:0.64%
EPS(LYR):-0.026
ROE:-6.73%
ROA:-0.93%
PB:3.22
PE(LYR):-65.72
PS:6.73

Loading ...

Sihuan Pharmaceutical Unit's New Drug Application for Breast Cancer Drug Gets China Nod

MT Newswires Live
·
May 16

Sihuan Pharmaceutical's Xuanyuening® Tablets Approved for Dual Indications, Marking Breakthrough in Breast Cancer Treatment

Reuters
·
May 16

BRIEF-Sihuan Pharma Says Bireociclib Tablets As Monotherapy Granted Marketing Authorization By NMPA

Reuters
·
May 16

Xuanzhu Biopharmaceutical Gains NMPA Approval for Innovative Breast Cancer Drug

Reuters
·
May 15

Sihuan Pharmaceutical Buys Back Shares Worth HK$7 Million

MT Newswires Live
·
May 13

BRIEF-Sihuan Pharma Repurchases Total Of 10 Million Shares Of Company

Reuters
·
May 12

BRIEF-Sihuan Pharma Repurchases 20 Million Shares At Average Price Of HK$0.7342 Per Share

Reuters
·
May 06

Sihuan Pharmaceutical Files Next Day Disclosure Return to HKEX Announcing Repurchase of 20 Million Shares at HKD 0.73-0.74 Each

Reuters
·
May 06

Sihuan Pharmaceutical Buys Back Shares

MT Newswires Live
·
May 05

BRIEF-Sihuan Pharma Says On 30 April And 2 May Repurchased 3.4 Million Shares

Reuters
·
May 02

BRIEF-Sihuan Pharma Repurchases Total Of 1.9 Million Shares

Reuters
·
Apr 29

BRIEF-Sihuan Pharma Will Conduct On-Market Share Repurchase Of Up To HK$500 Million In Aggregate

Reuters
·
Apr 28

Sihuan Pharmaceutical Unit's Diabetes Drug Gets Registration Approval in China

MT Newswires Live
·
Apr 24

BRIEF-Sihuan Pharma Says Dapagliflozin Tablets Obtained Drug Registration Approval From NMPA

Reuters
·
Apr 23

BRIEF-Sihuan Pharma Repurchased 10 Mln Shares At Average Price Of HK$0.6274 Per Share

Reuters
·
Apr 16

Sihuan Pharmaceutical Buys Back Shares

MT Newswires Live
·
Apr 10

BRIEF-Sihuan Pharma Intends To Exercise Its Powers Under General Mandate To Repurchase Shares Of Co

Reuters
·
Apr 09

BRIEF-Sihuan Pharma Repurchased A Total Of 15 Million Shares Of Co

Reuters
·
Apr 08

Sihuan Pharmaceutical Unit Gets China Nod for Facial Filler

MT Newswires Live
·
Apr 03

BRIEF-Sihuan Pharma Obtains Approval For Injectable Polycaprolactone Microsphere Facial Filler

Reuters
·
Apr 02